前列地尔脂微球载体联合甲钴胺治疗糖尿病周围神经病变被引量：7

下载PDF

导出

摘要目的观察前列地尔脂微球载体联合甲钴胺治疗糖尿病周围神经病变的疗效。方法60例糖尿病周围神经病变患者随机分为两组,观察组30例给予前列地尔脂微球载体10μg加入生理盐水250ml静脉滴注,1次/d,甲钴胺口服500μg,3次/d;对照组30例单用甲钴胺口服500μg,3次/d。两组疗程均为1个月。观察两组治疗前后的疗效,以测定神经传导速度为客观标准。结果观察组治疗后总有效率为85%,对照组为70%(P<0.01);治疗后的神经传导速度较治疗前有所提高。结论前列地尔脂微球载体联合甲钴胺治疗糖尿病周围神经病变的疗效优于单用甲钴胺。

作者张扬冉建民

机构地区暨南大学附属第四医院

出处《广东医学》 CAS CSCD 北大核心 2007年第7期1173-1174,共2页 Guangdong Medical Journal

关键词糖尿病神经病变前列地尔脂微球载体甲钴胺

分类号 R587.2 [医药卫生—内分泌]

引文网络
相关文献

参考文献7

1NASSERI K,STRIJERS R L,DEKHUIJZEN L S,et al.Reproducibility of different methods for diagnosis and monitoring diabetic neuopathy[J].Electromyogr Clin Neuophysial,1998,38 (5):295-299.
2ANONYNOUS.Report of the expert committee on the diagnosis and classitication of diabetes mellitus; report of the export committee on the diagnosis and classification of diabetes mellitus[J].Diabetes Care,1997,20 (7):1 183-1 197.
3廖二元超楚生.内分泌学[M].北京：人民卫生出版社,2001.610-611.
4李翔,刘志民.糖尿病周围神经病变代谢与分子机制研究进展[J].医学综述,2006,12(1):26-28. 被引量：4
5童光焕.糖尿病并发周围神经病变的诊断与治疗[J].中级医刊,1997,32(4):14-16. 被引量：24
6黄敬.前列腺素E_1(LipoPGE_1)治疗糖尿病周围神经病变的机制探讨[J].中国社区医师（医学专业）,2006,8(2):25-26. 被引量：1
7李光伟.甲钴胺治疗糖尿病神经病变的临床观察[J].中华内科杂志,1999,38(1):14-17. 被引量：243

二级参考文献19

1张蜀平，中华医学会第五次全国内分泌学术会议论文汇编，1997年，60页
2Michael B.Biochemistry and molecular cell biology of diabetic comp-lications[J].Nature,2001,414(6865):813.820.
3King RHM.The role of glycation in the pathogenesis of diabetic polyneuropathy[J].J Clin Pathol Mol Pathol,2001,54(6):400-408.
4Rosen P, Nawroth P, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a sununs.ry of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society[J]. Diabetes Metab Bes Bev,2001, 17(3) : 189-212.
5Metodlewa D, Keska C. Reactive oxygen species and reactive nitrogen species: relevance to cyto(neum) toxic events and nettrologic disorders.An overview[J]. Neurotox Res,2000,1(3) : 197-233.
6Corm K J, Ullman MD, Eisenhauer PB, et al. Decreased expression of the NADH:ubiquinone oxidoreductase(complex I) subunit 4 in l-methyl-4-phenylpyridinium-treated human neuroblastoma SH-SY5Y cells[J]. Neurosci Lett,2001,306(3) : 145-148.
7Paschen W, Mengesdorf T, Althausen 5, et al. Peroxidstive stress selectively down-resulates the neuronal stress response activaed under conditions of endoplasmic reticulum dysfunction [J].J Neurnehem, 2001,76(6) : 1916-1924.
8Pugazhenthi S, Nesterova A, Jambal P, et al. Oxidative atnsss mediated down regulation of bel-2 promoter in hiplxwaunpal neurons[J] .J Neuroehem, 2003,84(5) :982-996.
9Nagley P,Zhang C,Lim ML, et al. Mitochondria] DNA deletions pandlel age-linked decline in rat sensory nerve function[J]. Neurobiol Aging, 2001,22 ( 4 ) : 635-643.
10Gina ML'Andrea MV, Eva LF. The role of growth factors in diabetic peripheral neuropathy[J] .J Peri Nerv Sys,2004,9(1) :26-53.